Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Prospectus relating to Infant Bacterial Therapeutics’ rights issue published
January 10, 2018
To access the press release, please read the following disclaimer
here
.
Latest press releases
2026-09-21 09:00
FDA Grants Infant Bacterial Therapeutics AB’s Request for a Type B Pre-BLA Meeting
2026-09-18 10:40
NOMINATION COMMITTEE FOR INFANT BACTERIAL THERAPEUTICS AB (PUBL) FOR THE ANNUAL GENERAL MEETING 2027
Regulatory
2026-08-26 07:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – June 30, 2026
Regulatory
2026-07-07 12:05
Infant Bacterial Therapeutics CFO Leaves the Company
Regulatory
2026-05-07 17:15
Annual General Meeting of Infant Bacterial Therapeutics
Regulatory